Long
VXRT Breakout Stock Alert Update
BREAKOUT STOCK ALERT UPDATE
VXRT - Vaxart, Inc. - Common Stock
Initial Alert Price: $6.8
Price High: $12.74
% Gains/Losses: 87.35%
(+66.85% More Than Expected)
Potential Stop Loss: $12.103
VXRT is currently down 58.85% in today's trading session after reporting that neutralizing antibodies were not detected in volunteers after a single dose of its experimental oral COVID-19 vaccine candidate, VXA-CoV2-1, in a Phase 1 trial of 35 healthy adults. Researchers believe the antibodies play an important role in defending cells against the virus. This was the worse plunge for the stock since November 2012 and fortunately we updated everyone yesterday with concerns of consolidation and pullbacks but not to this extent. #Breakout #Stocks #Trading #Investing #Alerts #StockMarket #Daily #News #Today
VXRT - Vaxart, Inc. - Common StockInitial Alert Price: $6.8
Price High: $12.74
% Gains/Losses: 87.35%
(+66.85% More Than Expected)
Potential Stop Loss: $12.103
VXRT is currently down 58.85% in today's trading session after reporting that neutralizing antibodies were not detected in volunteers after a single dose of its experimental oral COVID-19 vaccine candidate, VXA-CoV2-1, in a Phase 1 trial of 35 healthy adults. Researchers believe the antibodies play an important role in defending cells against the virus. This was the worse plunge for the stock since November 2012 and fortunately we updated everyone yesterday with concerns of consolidation and pullbacks but not to this extent. #Breakout #Stocks #Trading #Investing #Alerts #StockMarket #Daily #News #Today
Pubblicazioni correlate
Declinazione di responsabilità
Le informazioni e le pubblicazioni non sono intese come, e non costituiscono, consulenza o raccomandazioni finanziarie, di investimento, di trading o di altro tipo fornite o approvate da TradingView. Per ulteriori informazioni, consultare i Termini di utilizzo.
Pubblicazioni correlate
Declinazione di responsabilità
Le informazioni e le pubblicazioni non sono intese come, e non costituiscono, consulenza o raccomandazioni finanziarie, di investimento, di trading o di altro tipo fornite o approvate da TradingView. Per ulteriori informazioni, consultare i Termini di utilizzo.